Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 20319-20320 [2013-07828]
Download as PDF
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 65 / Thursday, April 4, 2013 / Notices
related dementias on people with the
disease and their caregivers. During the
April meeting, the Advisory Council
will hear a presentation from an
international partner on their efforts to
address Alzheimer’s disease. There will
be a presentation on the priorities set
during the May 2012 research summit
and the milestones for achieving the
2025 goal. The federal partners will
provide an update on progress
implementing the National Plan to
Address Alzheimer’s Disease and
discuss highlights of the 2013 Update to
the National Plan.
DATES: The meeting will be held on
April 29, 2013 from 9:00 am to 5:00 pm
EDT.
ADDRESSES: The meeting will be held at
the U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 800, Washington,
DC 20201.
Comments: Time is allocated on the
agenda to hear public comments. In lieu
of oral comments, formal written
comments may be submitted for the
record to Helen Lamont, Ph.D., OASPE,
200 Independence Avenue SW., Room
424E, Washington, DC 20201.
Comments may also be sent to
napa@hhs.gov. Those submitting
written comments should identify
themselves and any relevant
organizational affiliations.
FOR FURTHER INFORMATION CONTACT:
Helen Lamont, Ph.D. (202) 690–7996,
helen.lamont@hhs.gov. Note: Seating
may be limited. Those wishing to attend
the meeting must send an email to
napa@hhs.gov and put ‘‘April 29
meeting attendance’’ in the Subject line
by Friday, April 19, 2013, so that their
names may be put on a list of expected
attendees and forwarded to the security
officers at the Department of Health and
Human Services. Any interested
member of the public who is a non-U.S.
citizen should include this information
at the time of registration to ensure that
the appropriate security procedure to
gain entry to the building is carried out.
Although the meeting is open to the
public, procedures governing security
and the entrance to Federal buildings
may change without notice. If you wish
to make a public comment, you must
note that within your email.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is given under the
Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting: The
Advisory Council will hear a
presentation from an international
partner on their efforts to address
Alzheimer’s disease and will discuss
ways to collaboration internationally.
VerDate Mar<15>2010
14:48 Apr 03, 2013
Jkt 229001
20319
There will be a presentation on the
priorities set during the May 2012
research summit and the milestones for
achieving the 2025 goal. The federal
partners will provide an update on
progress implementing the National
Plan to Address Alzheimer’s Disease
and discuss highlights of the 2013
Update to the National Plan.
Procedure and Agenda: This meeting
is open to the public.
Authority: 42 U.S.C. 11225; Section 2(e)(3)
of the National Alzheimer’s Project Act. The
panel is governed by provisions of Public
Law 92–463, as amended (5 U.S.C. Appendix
2), which sets forth standards for the
formation and use of advisory committees.
Buford Highway NE., Mailstop F63,
Atlanta, Georgia 30341, Telephone:
(770) 488–4281.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Dated: March 22, 2013.
Donald Moulds,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2013–07428 Filed 4–3–13; 8:45 am]
[FR Doc. 2013–07827 Filed 4–3–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review.
The meeting announced below
concerns Research Grants for Preventing
Violence and Violence Related Injury,
Funding Opportunity Announcement
(FOA) CE13–002, Initial Review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned SEP:
Time and Date:
9:00 a.m.–6:00 p.m., May 15–16, 2013
(Closed).
Place: Georgian Terrace, 659
Peachtree Street NE., Atlanta, Georgia
30308.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research Grants for Preventing
Violence and Violence Related Injury,
FOA CE13–002’’.
Contact Person for More Information:
Jane Suen, Dr.P.H., M.S., M.P.H.,
Scientific Review Officer, CDC, 4770
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Conducting Public Health
Research in Kenya, FOA GH10–003;
Conducting Public Health Research in
Thailand by the Ministry of Public
Health (MOPH), FOA GH11–002;
Conducting Public Health Research in
China, FOA GH12–005; Strengthening
Disease Prevention Research Capacity
for Public Health Action in Guatemala
and the Central American Region, FOA
GH13–001; Strengthening the
Monitoring and Evaluation of Programs
for the Elimination and Control of
Neglected Tropical Diseases in Africa,
FOA GH13–002; Detecting Etiologies of
Emerging Infectious Diseases at the
Regional Level—Western Ghat Region of
Karnataka and Kerala, India, FOA
GH13–003; Strengthening Surveillance
for Japanese Encephalitis in India, FOA
GH13–004; Monitoring and Evaluation
of Malaria Control and Elimination
Activities, FOA GH13–005; and
Research and Technical Assistance for
Public Health Interventions in Haiti to
Support Post-earthquake
Reconstruction, Cholera and HIV/AIDS,
FOA GH13–006, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–5:00 p.m.,
May 6, 2013 (Closed)
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
E:\FR\FM\04APN1.SGM
04APN1
20320
Federal Register / Vol. 78, No. 65 / Thursday, April 4, 2013 / Notices
wreier-aviles on DSK5TPTVN1PROD with NOTICES
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Conducting Public Health Research in
Kenya, FOA GH10–003; Conducting
Public Health Research in Thailand by
the Ministry of Public Health (MOPH),
FOA GH11–002; Conducting Public
Health Research in China, FOA GH12–
005; Strengthening Disease Prevention
Research Capacity for Public Health
Action in Guatemala and the Central
American Region, FOA GH13–001;
Strengthening the Monitoring and
Evaluation of Programs for the
Elimination and Control of Neglected
Tropical Diseases in Africa, FOA GH13–
002; Detecting Etiologies of Emerging
Infectious Diseases at the Regional
Level—Western Ghat Region of
Karnataka and Kerala, India, FOA
GH13–003; Strengthening Surveillance
for Japanese Encephalitis in India, FOA
GH13–004; Monitoring and Evaluation
of Malaria Control and Elimination
Activities, FOA GH13–005; and
Research and Technical Assistance for
Public Health Interventions in Haiti to
Support Post-earthquake
Reconstruction, Cholera and HIV/AIDS,
FOA GH13–006, initial review.’’
Contact Person for More Information:
Lata Kumar, Scientific Review Officer,
CGH Science Office, Center for Global
Health, CDC, 1600 Clifton Road, NE.,
Mailstop D–69, Atlanta, Georgia 30033,
Telephone (404) 639–7618.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–07828 Filed 4–3–13; 8:45 am]
BILLING CODE 4163–18–P
VerDate Mar<15>2010
14:48 Apr 03, 2013
Jkt 229001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10457, CMS–
10428 and CMS–10458]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection; Title of
Information Collection: MAC
Satisfaction Indicator (MSI) Participant
Information Registration Form; Use:
Section 1874(A)(b)(3)(B) of the Social
Security Act requires that provider
satisfaction be a performance standard
for the work of Medicare Administrative
Contractors (MACs). In order to gain
provider feedback regarding their
satisfaction with their MACs, we need
to be able to contact the providers.
Therefore, we need accurate contact
information to: select from for a random
sample, get the survey to the
appropriate respondent, and increase
response rates. The survey will not be
added to this package; instead, it will be
processed under a different control
number via an Interagency Agreement.
Form Number: CMS–10457 (OCN: 0938New). Frequency: Yearly; Affected
Public: Private sector (business or other
for-profit and not-for-profit institutions).
Number of Respondents: 150,000. Total
Annual Responses: 150,000. Total
Annual Hours: 2,500. (For policy
questions regarding this collection
contact Teresa Mundell at 410–786–
AGENCY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
9176. For all other issues call 410–786–
1326.)
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title: PCIP
Authorization to Share Personal Health
Information; Use: On March 23, 2010,
the President signed into law H.R. 3590,
the Patient Protection and Affordable
Care Act (Affordable Care Act), Public
Law 111–148. Section 1101 of the law
establishes a ‘‘temporary high risk
health insurance pool program’’ (which
has been named the Pre-Existing
Condition Insurance Plan, or PCIP) to
provide health insurance coverage to
currently uninsured individuals with
pre-existing conditions. The law
authorizes HHS to carry out the program
directly or through contracts with states
or private, non-profit entities.
Reapproval of this package is being
requested as a result of CMS, in its
administration of the PCIP program,
serving as a covered entity under the
Health Insurance Portability and
Accountability Act (HIPAA). Without a
valid authorization, the PCIP program is
unable to disclose information, with
respect to an applicant or enrollee,
about the status of an application,
enrollment, premium billing or claim, to
individuals of the applicant’s or
enrollee’s choosing. The HIPAA
Authorization Form has been modeled
after CMS’ Medicare HIPAA
Authorization Form (OMB control
number 0938–0930) and is used by
applicants or enrollees to designate
someone else to communicate with PCIP
about their protected health information
(PHI).
Unless permitted or required by law,
the Health Insurance Portability and
Accountability Act (HIPAA) Privacy
Rule (§ 164.508) prohibits CMS’ PCIP
program (a HIPAA covered entity) from
disclosing an individual’s protected
health information without a valid
authorization. In order to be valid, an
authorization must include specified
core elements and statements.
CMS will make available to PCIP
applicants and enrollees a standard,
valid authorization to enable
beneficiaries to communicate with PCIP
about their personal health information.
This is a critical tool because the
population the PCIP program serves is
comprised of individuals with preexisting conditions who may be
incapacitated and need an advocate to
help them apply for or receive benefits
from the program. This standard
authorization will simplify the process
of requesting information disclosure for
beneficiaries and minimize the response
time for the PCIP program.
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 78, Number 65 (Thursday, April 4, 2013)]
[Notices]
[Pages 20319-20320]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07828]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Conducting Public Health
Research in Kenya, FOA GH10-003; Conducting Public Health Research in
Thailand by the Ministry of Public Health (MOPH), FOA GH11-002;
Conducting Public Health Research in China, FOA GH12-005; Strengthening
Disease Prevention Research Capacity for Public Health Action in
Guatemala and the Central American Region, FOA GH13-001; Strengthening
the Monitoring and Evaluation of Programs for the Elimination and
Control of Neglected Tropical Diseases in Africa, FOA GH13-002;
Detecting Etiologies of Emerging Infectious Diseases at the Regional
Level--Western Ghat Region of Karnataka and Kerala, India, FOA GH13-
003; Strengthening Surveillance for Japanese Encephalitis in India, FOA
GH13-004; Monitoring and Evaluation of Malaria Control and Elimination
Activities, FOA GH13-005; and Research and Technical Assistance for
Public Health Interventions in Haiti to Support Post-earthquake
Reconstruction, Cholera and HIV/AIDS, FOA GH13-006, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 11:00 a.m.-5:00 p.m., May 6, 2013 (Closed)
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
[[Page 20320]]
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Conducting Public Health Research in Kenya, FOA GH10-003;
Conducting Public Health Research in Thailand by the Ministry of Public
Health (MOPH), FOA GH11-002; Conducting Public Health Research in
China, FOA GH12-005; Strengthening Disease Prevention Research Capacity
for Public Health Action in Guatemala and the Central American Region,
FOA GH13-001; Strengthening the Monitoring and Evaluation of Programs
for the Elimination and Control of Neglected Tropical Diseases in
Africa, FOA GH13-002; Detecting Etiologies of Emerging Infectious
Diseases at the Regional Level--Western Ghat Region of Karnataka and
Kerala, India, FOA GH13-003; Strengthening Surveillance for Japanese
Encephalitis in India, FOA GH13-004; Monitoring and Evaluation of
Malaria Control and Elimination Activities, FOA GH13-005; and Research
and Technical Assistance for Public Health Interventions in Haiti to
Support Post-earthquake Reconstruction, Cholera and HIV/AIDS, FOA GH13-
006, initial review.''
Contact Person for More Information: Lata Kumar, Scientific Review
Officer, CGH Science Office, Center for Global Health, CDC, 1600
Clifton Road, NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone
(404) 639-7618.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-07828 Filed 4-3-13; 8:45 am]
BILLING CODE 4163-18-P